TAK-375: Treatment of Insomnia Treatment of Circadian Rhythm Disorders Melatonin MT1/MT2 Agonist

Drugs of the Future

Volumn 28, Issue 10, 2003, Pages 950-958

  Chilman Blair, K ^a   Castaner J ^a   Silvestre, J S ^a   Bayes M ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; MELATONIN RECEPTOR 1 AGONIST; PROPIONAMIDE DERIVATIVE; RAMELTEON; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; FATIGUE; FEMALE; HEADACHE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS; IC 50; INSOMNIA; MALE; NAUSEA; NONHUMAN; PAIN; PHARYNX DISEASE; PHASE 3 CLINICAL TRIAL; REACTION ANALYSIS; REVIEW; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; SORE THROAT; STRUCTURE ANALYSIS; SUPRACHIASMATIC NUCLEUS;

EID: 0347513102     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2003.028.10.763214     Document Type: Review

References (25)

1. Miyamoto, M., Ohkawa, S., Uchikawa, O., Fukatsu, K. (Takeda Chemical Industries, Ltd.). Tricyclic cpds., their production and use. EP 0885210, JP 1998287665, JP 1999152281, WO 9732871.
2. Ohkawa, S. Discovery of the novel melatonin agonist TAK-375. 22nd Symp Med Chem (Nov 27-29, Shizuoka) 2002, Abst IL 11.
3. Uchikawa, O., Fukatsu, K., Tokunoh, R. et al. Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. J Med Chem 2002, 45: 4222-39.
4. Perreau-Lenz, S., Kalsbeek, A., Garidou, M.L., Wortel, J., van der Vliet, J., van Heijningen, C., Simonneaux, V., Pevet, P., Buijs, R.M. Suprachiasmatic control of melatonin synthesis in rats: Inhibitory and stimulatory mechanisms. Eur J Neurosci 2003, 17: 221-8.
5. Zisapel, N. Circadian rhythm sleep disorders: Pathophysiology and potential approaches to management. CNS Drugs 2001, 15: 311-28.
6. Monti, J.M., Cardinali, D.P. A critical assesment of the melatonin effect on sleep in humans. Biol Signals Recept 2000, 9: 328-39.
7. Karasek, M., Reiter, R.J., Cardinali, D.P., Pawlikowski, M. Future of melatonin as a therapeutic agent. Neuroendocrinol Lett 2002, 23(Suppl. 1): 118-21.
8. Hirai, K., Kato, K., Nishiyama, H., Hinuma, S., Uchikawa, O., Ohkawa, S., Miyamoto, M. TAK-375 and its metabolites are selective agonists at MLs1s receptors. Sleep 2003, 26(Suppl.): Abst 0193.C.
9. 1-selective melatonin receptor agonist. Int J Neuropsychopharmacol, 2000. 3(Suppl. 1): Abst P.03.130.
10. Liu, C., Weaver, D., Jin, X., Shearman, L., Pieschl, R., Gribkoff, V., Reppert, S.M. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997, 19: 91-102.
11. Vanecek, J. Cellular mechanisms of melatonin action. Physiol Rev 1998, 78: 687-721.
12. Miyamoto, M., Kato, K., Hirai, K., Uchikawa, O., Ohkawa, S. TAK-375 and its active metabolite: Lack of binding to non-ML receptor binding sites. Sleep 2003, 26(Suppl.): Abst 0194.C.
13. 1-selective melatonin receptor agonist, on entrainment function in circadian rhythm. 76th Annu Meet Jpn Pharmacol Soc(March 24-26, Fukuoka) 2003, Abst 3D0854.
14. 1-selective melatonin receptor agonist, in experimental animals. Int J Neuropsychopharmacol 2000, 3(Suppl. 1): Abst P.03.125.
15. Fukatsu, K., Uchikawa, O., Kato, K., Nishikawa, H., Hinuma, S., Miyamoto, M., Ohkawa, S. Synthesis and sleep promoting action of TAK-375, a novel melatonin agonist. 20th Symp Med Chem (Dec 6-8, Tokyo) 2000, Abst 1 P-28.
16. Yukuhiro, N., Kimura, H., Nishikawa, H., Ohkawa, S., Miyamoto, M. Effects of TAK-375, a novel melatonin receptor agonist, on sleep in freely moving monkeys. Int J Neuropsychopharmacol 2000, 3(Suppl. 1): Abst P.03.127.
17. Yukuhiro, N., Nishikawa, H., Kimura, H., Ohkawa, S., Miyamoto, M. Sleep in freely moving monkeys: Comparison of TAK-375, melatonin, and zolpidem. Sleep 2003, 26(Suppl.): Abstract 0195.C.
18. Yukuhiro, N., Nishikawa, H., Kimura, H., Ohkawa, S., Miyamoto, M. Effects of TAK-375, a novel melatonin receptor agonist, on sleep in freely moving monkeys at nighttime. Jpn J Pharmacol 2001, 85(Suppl. 1): Abst P-791.
19. Greenblatt, D.J., Harmatz, J.S. Effect of age and gender on the pharmacodynamics of TAK-375: Tests of sedation, psychomotor function, and memory. Sleep 2003, 26(Suppl.): Abst 0197.C.
20. Greenblatt, D.J., Harmatz, J.S., Stubbs, C. Effect of age on the pharmacokinetics and pharmacodynamics of TAK-375: A novel selective ML-1 receptor agonist under investigation for the treatment of insomnia. 11th Int Congr Int Psychogeriatr Assoc (Aug 17-22, Chicago) 2003, Abst PA-015.
21. Greenblatt, D.J. Harmatz, J.S. Age and gender effects on the pharmacokinetics of TAK-375. Sleep 2003, 26(Suppl.): Abst 0198.C.
22. Stubbs, C., Karim, A. A safety, tolerance, and pharmacokinetic study of five single doses of TAK-375 in healthy adults. Sleep 2003, 26(Suppl.): Abst 0187.C.
23. Roth, T., Walsh, J. Phase II study of the selective ML-1 receptor agonist TAK-375 in a first night effect model of transient insomnia. Sleep 2003, 26(Suppl.): Abst 0739.L.
24. Erman, M., Seiden, D., Zammit, G. Phase II study of the selective ML-1 receptor agonist TAK-375 in subjects with primary chronic insomnia. Sleep 2003, 26(Suppl.): Abst 0748.L.
25. Ohkawa, S., Uchikawa, O., Fukatsu, K., Tokunoh, R., Kawada, M., Matsumoto, K., Imai, Y., Kato, K., Nishikawa, H., Miyamoto, M. Synthesis of a novel series of tricyclic indan derivatives as melatonin agonists. 16th Int Symp Med Chem (Sept 18-22, Bologna) 2000, Abst PB-108.